In this interview, April Watkins, DNP, APRN, discusses the expanding role of GLP-1 receptor agonists within atrial fibrillation risk factor modification programs.
In this interview, April Watkins, DNP, APRN, discusses the expanding role of GLP-1 receptor agonists within atrial fibrillation risk factor modification programs.
Professor Damijan Miklavcic joins Bradley Knight, MD, to discuss the key takeaways from the 2026 HRS/EHRA Scientific Statement on pulsed field ablation (PFA) for cardiac arrhythmias.
Professor Damijan Miklavcic joins Bradley Knight, MD, to discuss the key takeaways from the 2026 HRS/EHRA Scientific Statement on pulsed field ablation (PFA) for cardiac arrhythmias.